Literature DB >> 24914419

Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media.

Simone Maurea1, Pier Paolo Mainenti1, Annamaria Tambasco1, Massimo Imbriaco1, Carmine Mollica1, Ettore Laccetti1, Luigi Camera1, Raffaele Liuzzi1, Marco Salvatore1.   

Abstract

To compare the diagnostic value of gadolinium (Gd) and ultrasmall superparamagnetic iron oxide (SPIO) contrast media for characterization of focal liver lesions (FLL), we retrospectively evaluated the results of magnetic resonance (MR) imaging in 68 patients (40 M, 28 F, age from 22 to 81 yrs) of which 36 with diagnosis of colo-rectal cancer, 26 with hepatic cirrhosis and 6 with incidental imaging detection of FLL. MR (Gyroscan Intera 1.5 T, Philips Medical Systems) study was performed using T1 and T2 fast-field-echo (FFE) and T2 turbo-spin-echo (TSE) sequences in axial and coronal views. Dynamic multi-phases gadolinium Gd-enhanced T1-FFE-Bh images were obtained in arterial, portal and equilibrium phases, followed by SPIO-enhanced T2-FFE scans. A qualitative analysis of pre- and post-contrast MR images to classify FLL as benign or malignant was performed using a 3-point scoring system: 0= benign; 1= suspicious for malignancy; 2= malignant. A total of 118 lesions were evaluated. In particular, histology (n=18), cytology (n=14) or clinical-imaging follow-up data (n=86) demonstrated 4 adenomas, 29 cysts, 3 focal steatosis, 25 hemangiomas, 1 focal vascular abnormality, 5 fibrotic lesions as well as 13 regenerative nodules, 6 dysplastic, 14 hepatocellular carcinomas (HCC), 17 metastasis and 1 cholangiocarcinoma. For MR imaging, diagnostic accuracy, sensitivity, specificity, positive (PPV) and negative (NPV) predictive values of Gd vs. SPIO images were respectively 83% vs. 92%, 79% vs. 74%, 85% vs. 99% (P=0.002), 68% vs. 96% (P=0.005) and 91% vs. 90%, respectively. The results suggest that SPIO-MR provides a diagnostic incremental value, as specificity and PPV, particularly to characterize FLL compared to Gd-MR; thus, we strongly recommend the use of SPIO when liver lesion characterization is requested and Gd images are uncertain.

Entities:  

Keywords:  MR imaging; contrast media; focal liver lesions (FLL); gadolinium; superparamagnetic iron oxide (SPIO)

Year:  2014        PMID: 24914419      PMCID: PMC4032916          DOI: 10.3978/j.issn.2223-4292.2014.01.02

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  38 in total

1.  Effectiveness of MR imaging in characterizing small hepatic lesions: routine versus expert interpretation.

Authors:  Gisela C Mueller; Hero K Hussain; Ruth C Carlos; Hanh V Nghiem; Isaac R Francis
Journal:  AJR Am J Roentgenol       Date:  2003-03       Impact factor: 3.959

2.  Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.

Authors:  Pier Paolo Mainenti; Marcello Mancini; Ciro Mainolfi; Luigi Camera; Simone Maurea; Antonietta Manchia; Michela Tanga; Francesco Persico; Pietro Addeo; Dario D'Antonio; Antonio Speranza; Luigi Bucci; Giovanni Persico; Leonardo Pace; Marco Salvatore
Journal:  Abdom Imaging       Date:  2009-06-27

3.  Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma.

Authors:  Y K Kim; C S Kim; Y M Han; G Park; S B Hwang; H C Yu
Journal:  Clin Radiol       Date:  2010-03-15       Impact factor: 2.350

4.  T2-weighted and diffusion-weighted MRI for discriminating benign from malignant focal liver lesions: diagnostic abilities of single versus combined interpretations.

Authors:  Hiroki Haradome; Luigi Grazioli; Mario Morone; Sebastiana Gambarini; Thomas C Kwee; Taro Takahara; Stefano Colagrande
Journal:  J Magn Reson Imaging       Date:  2012-01-13       Impact factor: 4.813

5.  Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.

Authors:  Y Tang; Y Yamashita; A Arakawa; T Namimoto; K Mitsuzaki; Y Abe; K Katahira; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1999-06       Impact factor: 3.959

6.  Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging.

Authors:  M Matsuo; M Kanematsu; K Itoh; K Ito; Y Maetani; H Kondo; N Kako; N Matsunaga; H Hoshi; J Shiraishi
Journal:  AJR Am J Roentgenol       Date:  2001-09       Impact factor: 3.959

7.  Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas.

Authors:  Young Kon Kim; Chong Soo Kim; Young Hwan Lee; Hyo Sung Kwak; Jeong Min Lee
Journal:  AJR Am J Roentgenol       Date:  2004-05       Impact factor: 3.959

Review 8.  Liver transplantation in patients with hepatocellular carcinoma.

Authors:  Myron Schwartz
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

Review 9.  Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

10.  Detection of small hepatocellular carcinoma: comparison of conventional gadolinium-enhanced MRI with gadolinium-enhanced MRI after the administration of ferucarbotran.

Authors:  Y K Kim; C S Kim; Y M Han
Journal:  Br J Radiol       Date:  2009-01-05       Impact factor: 3.039

View more
  13 in total

1.  Exponential growth of publications on carbon nanodots by Chinese authors.

Authors:  Junqing Wang; Hak Soo Choi; Yì-Xiáng J Wáng
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

2.  Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging.

Authors:  Yi-Xiang J Wang
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

Review 3.  Transcatheter embolization therapy in liver cancer: an update of clinical evidences.

Authors:  Yì-Xiáng J Wáng; Thierry De Baere; Jean-Marc Idée; Sébastien Ballet
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

Review 4.  A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging.

Authors:  Yì Xiáng J Wáng; Jean-Marc Idée
Journal:  Quant Imaging Med Surg       Date:  2017-02

Review 5.  Superparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: systematic review and meta-analysis.

Authors:  You-Wei Li; Zheng-Guang Chen; Ji-Chen Wang; Zong-Ming Zhang
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

Review 6.  Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Tin Nadarevic; Agostino Colli; Vanja Giljaca; Mirella Fraquelli; Giovanni Casazza; Cristina Manzotti; Davor Štimac; Damir Miletic
Journal:  Cochrane Database Syst Rev       Date:  2022-05-06

Review 7.  Non-invasive diagnostic imaging of colorectal liver metastases.

Authors:  Pier Paolo Mainenti; Federica Romano; Laura Pizzuti; Sabrina Segreto; Giovanni Storto; Lorenzo Mannelli; Massimo Imbriaco; Luigi Camera; Simone Maurea
Journal:  World J Radiol       Date:  2015-07-28

8.  A scientometric analysis on hepatocellular carcinoma magnetic resonance imaging research from 2008 to 2017.

Authors:  Da-Wei Yang; Xiao-Pei Wang; Zhen-Chang Wang; Zheng-Han Yang; Xue-Feng Bian
Journal:  Quant Imaging Med Surg       Date:  2019-03

9.  Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment.

Authors:  Yushuang Wei; Mengzhu Zhao; Fang Yang; Yang Mao; Hang Xie; Qibing Zhou
Journal:  Sci Rep       Date:  2016-06-30       Impact factor: 4.379

10.  Polymer-brush-afforded SPIO Nanoparticles Show a Unique Biodistribution and MR Imaging Contrast in Mouse Organs.

Authors:  Ting Chen; Yuki Mori; Chizuko Inui-Yamamoto; Yutaka Komai; Yoshiyuki Tago; Shinichi Yoshida; Yoshitsugu Takabatake; Yoshitaka Isaka; Kohji Ohno; Yoshichika Yoshioka
Journal:  Magn Reson Med Sci       Date:  2017-01-30       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.